One Sentence Summary: Fatty acid synthase is S-nitrosylated during adipogenesis.
INTRODUCTION
Fatty acid synthase (FAS), which is highly expressed in adipose tissue, liver, and lactating mammary glands, catalyzes the synthesis of palmitate from acetyl-CoA and malonyl-CoA in the presence of NADPH (1) (2) (3) . FAS is active as a homodimer, and each monomer has seven separate functional domains, including malonyl/acetyltransferase (MAT), β-ketoacyl synthase (KS), β-ketoacyl reductase (KR), dehydrase (DH), enoyl reductase (ER), thioesterase (TE), and acyl carrier protein (ACP) (4) . Although the monomer contains all the activities required for palmitate synthesis, dimer formation is essential for FAS function (5) (6) (7) (8) (9) . Several studies have reported that FAS is involved in the regulation of adipose tissue mass (1, (10) (11) (12) (13) (14) (15) (16) (17) (18) ) and a key enzyme regulating energy metabolism and a metabolic oncogene (19, 20) . Therefore, FAS has been considered as a potential target for the development of antiobesity and anti-cancer drugs (21-25). Expression of FAS is transcriptionally regulated by the sterol regulatory element binding protein-1c (SREBP-1c) and by upstream stimulatory factors 1 and 2 (USF1 and USF2) in response to feeding or to insulin (26, 27) . So far, however, nothing is known about the post-translational modification of FAS except that it is ubiquitinated (28, 29).
Nitric oxide (NO) is a critical signaling molecule that is involved in a number of physiological and pathological processes. When overproduced, NO is known to have harmful effects on cell function and survival (30-32). In contrast, within the physiological concentration range, NO plays a critical role as a regulator of cellular signaling pathways (33-35). A major mechanism mediating the biological function of NO is protein Snitrosylation, a posttranslational modification of proteins involving the addition of an NO + to 4 NO is reported to improve the β-oxidation of fatty acids through reversible protein Snitrosylation (40). NO is also known to impair the anti-lipolytic action of insulin in obesity through S-nitrosylation (41) and to enhance adipogenesis in primary human preadipocytes (42). However, little is known about the target proteins of S-nitrosylation during adipogenesis.
In the present study, we showed that FAS is S-nitrosylated during adipogenesis and that the S-nitrosylation of FAS increases its activity by enhancing dimerization, indicating that S-nitrosylation of FAS contributes to adipogenesis.
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RESULTS
Protein S-nitrosylation is required for adipocyte differentiation
To investigate whether NO is involved in the process of adipocyte differentiation, we first evaluated NO production during adipocyte differentiation (Fig. 1A) . The production of NO during adipocyte differentiation was estimated by measuring the total concentration of its oxidation metabolites, nitrite and nitrate, using an NO assay kit. Compared with the early differentiation period of adipocytes (days 0-2), there was a significant increase in total NO level in the supernatants of cells taken at the later differentiation period (days 6-8) (Fig. 1A) .
We next investigated whether protein S-nitrosylation, a major post-translational modification by NO, might have a unique role in adipogenesis. Protein S-nitrosylation can occur even at low levels of NO and can affect the activity and stability of specific proteins (36-39).
Immunofluorescence (IF) assay using an antibody against nitroso-cysteine showed that protein S-nitrosylation was higher in differentiated adipocytes (day 9) than in undifferentiated preadipocytes ( (Fig. 1D, 1E ). The better NO scavenger, cPTIO showed slightly more efficient inhibition of adipogenesis than PTIO at the same concentrations (Figs.
1D and 1E). To test the effect of NOS inhibitor on adipogenesis, we performed same experiments with NNA, a broad NOS inhibitor. We found that there was no effect of NNA on adipogenesis ( Supplementary Fig. 1A ). In agreement with a previous report (43), we could not see the expression of iNOS and nNOS during adipogenesis, whereas eNOS protein band was detectable only at the later differentiation stage (Day 14) (Supplementary Fig. 1B ).
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Increased S-nitrosylation and dimerization of FAS in differentiated adipocytes
Following a previous report on fatty acid metabolism and S-nitrosylation (40), we analyzed the levels of FAS, one of the essential proteins for lipid droplet formation during adipogenesis, in differentiated adipocytes. We confirmed that the levels of nitrosocysteine and FAS in more differentiated adipocytes (day 12) were higher than those in less differentiated adipocytes (day 2) (Fig. 2A) . The yellow color in the merged image of nitrosocysteine (green) and FAS (red) images implied that FAS was likely to be Snitrosylated (SNO-FAS) ( Fig. 2A) . We also performed the immunostaining for nitrosocysteine with negative controls to reaffirm antibody and detection specificity ( Supplementary Fig. 2 ). To confirm that the biotin-switch assay allows detection of SNO-FAS, the lysate of undifferentiated adipocytes was subjected to the assay after incubation in SNOC with or without the assay components, including methyl-methanethiosulfonate (MMTS), ascorbate, and N-[6-(biotinamido)hexyl]-3′-(2′-pyridyldithio)-propionamide (biotin-HPDP) (Fig. 2B) . In addition, we tested whether FAS in adipose tissue homogenates could be S-nitrosyated. We eliminated S-nitrosocysteine by treatment with UV-light and used this sample for negative control. We found that FAS was nitrosylated in human adipose tissue and the SNO-FAS in lysates was eliminated by UV-light (Fig. 2C ).
To test if SNOC-induced FAS nitrosylation is cPTIO sensitive, we incubated the cells with cPTIO before SNOC treatment and performed biotin switch assay. We found that SNOC-induced FAS nitrosylation was cPTIO sensitive (Supplementary Fig. 3 ). It has been reported that DEA-NONOate, another NO donor, can nitrosylate proteins (44 the SNO-FAS level was increased during adipocyte differentiation (Fig. 2D ). We also found that FAS dimer formation was increased during the later stage of adipocyte differentiation (day 9) (Fig. 2E ).
Dimerization and activation of FAS are mediated by NO
To identify whether FAS dimerization can be directly induced by NO, we examined the effect of exogenous NO on the dimerization level of FAS by non-denaturing PAGE and western blot analysis. We found that SNOC significantly increased FAS dimerization (Fig.   3A ). FAS dimer disappeared when cell lysates were boiled under reducing conditions, which suggested that FAS dimerization might be mediated through disulfide bonds. We then tested whether NO could influence FAS activity. Similar to the result with dimerization, the enzymatic activity of FAS was significantly higher in the lysate of ADSCs treated with fresh SNOC than in that treated with old SNOC, from which NO had dissipated (Fig. 3B ). important for FAS dimerization. Consistent with these results, the SNOC-induced increase in activity of the C161A, C1471A, or C2091A mutants was significantly lower than that of FAS-WT (Fig. 4C ). In addition, we examined the effect of cysteine to alanine mutation itself upon the basal enzymatic activity, and there was no significant difference versus FAS-WT ( Supplementary Fig. 4 ).
FAS is S-nitrosylated at
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DISCUSSION
There are conflicting views regarding the role of NO in adipogenesis. Several papers have reported that NO suppresses adipocyte differentiation, but others have shown that NO can enhance adipogenesis (42, 43, [45] [46] [47] . This discrepancy seems reasonable considering our results demonstrating that the production of NO was relatively low even though it increased significantly during adipogenesis ( Fig. 1A) and that SNOC has a biphasic effect on adipogenesis (Fig. 1C) . Taken together, these data lead us to assume that a small amount of free NO is required for adipogenesis, whereas a larger amount of NO may suppress adipogenesis.
Protein S-nitrosylation is a major reversible posttranslational modification by NO that regulates protein function and stability (36-39, 48-53). Interestingly, it has been reported that protein S-nitrosylation is increased in adipose tissue in a model of obesity (41). To explore the biological role of S-nitrosylation in adipogenesis, we first focused on FAS, the key enzyme of fatty acid synthesis. We found that FAS was S-nitrosylated under physiological conditions and the level of SNO-FAS was gradually increased during adipogenesis ( fatty acid oxidation. Therefore, the balance of the S-nitrosylation level might be a key signaling pathway regulating obesity.
Previous reports have shown that protein S-nitrosylation affects protein activity by enhancing protein dimerization of Drp1 (52) in the center of the interdomain of FAS, which is known to be important for catalytically active dimer formation (55) .
NO scavengers significantly inhibited adipogenesis. We suggest that the inhibition of SNO-FAS formation leading to FAS inactivation could be a possible signaling pathway by which NO scavengers inhibit adipogenesis. During adipocyte differentiation, the decrease in fatty acid synthesis is known to interrupt the cross-stimulation of C/EBPα and PPARγ, and leads to insufficient adipogenesis (56) (57) (58) . We assume that these events may have occurred in our experimental system, at least in part, when exposed to NO scavengers. Based on the data showing no effect of NOS inhibitor on adipogenesis ( Supplementary Fig. 1A ), we have a hypothesis that NO during adipogenesis in the present experiments could be coming from intracellular 'SNO pool' such as S-nitrosoglutathione (GSNO), SNOC and other SNOproteins, as suggested before (34). Though there are no previous reports about the higher thiol oxidation states of FAS, it is still possible that the further thiol oxidation of FAS can alter its activity in our experimental system. It is because reversible S-nitrosylation may facilitate further oxidation of the same cysteine thiol (59, 60) . In addition to affecting adipogenesis, fatty acids produced by FAS are known to stimulate other signaling pathways, including autophagy and miRNA signaling (61, 62) . FAS has also received much attention regarding 
MATERIALS AND METHODS
Reagents and antibodies
The NO scavengers 2-Phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (PTIO) Louis, MO, USA). S-nitrosocysteine (SNOC) was prepared as described previously (63) . 
NO assay
For quantitative determination of the nitric oxide level, a Nitric Oxide Assay Kit (Colorimetric, ab65328) from Abcam (Cambridge, UK) was used. Total nitrate and nitrite levels were measured in a two-step process. The first step converts nitrate to nitrite with nitrate reductase. The second step uses Griess Reagents to convert nitrite to a deep purple azo compound. The amount of azochromophore reflects the amount of nitric oxide in the samples.
The absorbance at 550 nm was immediately recorded and compared to the absorbance of a freshly prepared standard curve of sodium nitrite.
Immunocytochemistry
Adipocytes were fixed for 1 h in 10% formalin in PBS followed by permeabilization in 0.1% Triton X-100 for 10 min. Blocking was performed in PBS containing 10% normal goat serum for 1 hour. The fixed cells were incubated using anti-FAS or anti-nitrosocysteine overnight in the blocking solution. The cells were washed and incubated for 1 h with either Alexa-Fluor-488-conjugated goat anti-mouse antibody (A10680) or Alexa-Fluor-594-conjugated goat anti-rabbit antibody (A11012) (Molecular Probes, Carlsbad, CA, USA).
After washing, the cells were mounted in a mounting medium containing DAPI. Cells were observed using an EVOS FL cell imaging system (Life Technologies, Carlsbad, CA, USA).
Formalin solution (HT501128), goat serum (G9023), and fluoroshield mounting medium with DAPI (F6057) were purchased from Sigma-Aldrich (St. Louis, MO, USA). 
FAS constructs
Oil Red O staining
Adipocyte differentiation was assessed using an Oil Red O stain (O0625, SigmaAldrich, St. Louis, MO, USA) as an indicator of intracellular lipid accumulation. After ADSC differentiation to adipocytes, cells were washed twice with PBS, fixed with 10% formalin in PBS for 1 h, and then washed with 60% isopropanol, before being allowed to dry completely.
Adipocytes were stained with 0.2% Oil Red O reagent for 10 min at room temperature and washed with H 2 O four times. Each sample was eluted with 100% isopropanol for 10 min and absorbance was measured at 500 nm using a spectrophotometer. To visualize the nucleus, adipocytes were counterstained with a hematoxylin reagent (H3136, Sigma-Aldrich, St.
Louis, MO, USA) for 2 min and washed twice with H 2 O. The level of adipocyte differentiation was observed using an inverted phase microscope.
Biotin-switch assay
Cell lysates or adipose tissue lysates were prepared in HENTS buffer (100 mM HEPES, 1 mM EDTA, 0.1 mM neocuproine, 1% Triton X-100, and 0.1% SDS, pH 7.4). The biotinswitch assay was carried out as described previously (64) 
FAS activity assay
The FAS activity assay was performed as previously described (65) 
Statistical analysis
The statistical analyses of the data were analyzed with the Student's t test or by oneway analysis of variance (ANOVA). Data are expressed as means ± S.D. of at least three independent experiments. P-value of less than 0.05 was considered statistically significant. B. On day 9 following IDXT incubation, immunofluorescence staining was performed on the control and the 9-day differentiated adipocyte samples using an anti-nitrosocysteine antibody. or its cysteine mutants (C161A, C1127A, C1471A, and C2091A) and exposed to SNOC or
Old SNOC. The cell lysates were subsequently subjected to a biotin-switch assay (A) or to non-denaturing PAGE (B). After the blots were developed with a primary antibody against FLAG, they were stripped and re-probed with a primary antibody against FAS. ** ** **
